We are live on ! Find out more
SC

Scotia Capital Portfolio holdings

AUM $24.3B
1-Year Est. Return 29.21%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+29.21%
3 Year Est. Return
+67.1%
5 Year Est. Return
+76.68%
10 Year Est. Return
+222.34%
AUM
$15.5B
AUM Growth
+$1.69B
Cap. Flow
+$144M
Cap. Flow %
0.93%
Top 10 Hldgs %
34.75%
Holding
847
New
72
Increased
341
Reduced
338
Closed
54

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$24.3M
2
ENB icon
Enbridge
ENB
+$22.4M
3
TU icon
Telus
TU
+$17.1M
4
RY icon
Royal Bank of Canada
RY
+$15M
5
MCD icon
McDonald's
MCD
+$12.5M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$12.8M
2
DHR icon
Danaher
DHR
+$11.7M
3
PFE icon
Pfizer
PFE
+$11.1M
4
IBM icon
IBM
IBM
+$8.13M
5
HON icon
Honeywell
HON
+$7.16M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Technology 13.92%
3 Communication Services 10.12%
4 Energy 9.18%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
751
MiMedx Group
MDXG
$606M
$155K ﹤0.01%
17,706
-133
-0.7% -$974
TLRY icon
752
Tilray
TLRY
$602M
$151K ﹤0.01%
6,565
-407
-6% -$7.84K
PSLV icon
753
Sprott Physical Silver Trust
PSLV
$12.9B
$146K ﹤0.01%
17,301
+2,406
+16% +$19K
DBO icon
754
Invesco DB Oil Fund
DBO
$356M
$142K ﹤0.01%
+10,204
New +$162K
MPT
755
Medical Properties Trust
MPT
$2.79B
$132K ﹤0.01%
26,925
-3,722
-12% -$18.2K
CLSK icon
756
CleanSpark
CLSK
$3.46B
$130K ﹤0.01%
11,810
+1,500
+15% +$9.34K
TEVA icon
757
Teva Pharmaceuticals
TEVA
$40.5B
$128K ﹤0.01%
12,267
-30
-0.2% -$280
GOVZ icon
758
iShares 25+ Year Treasury STRIPS Bond ETF
GOVZ
$263M
$126K ﹤0.01%
+2,570
New +$110K
HLN icon
759
Haleon
HLN
$43.8B
$126K ﹤0.01%
15,253
+153
+1% +$1.26K
ESRT icon
760
Empire State Realty Trust
ESRT
$843M
$123K ﹤0.01%
+12,658
New +$110K
OTLK icon
761
Outlook Therapeutics
OTLK
$193M
$112K ﹤0.01%
14,204
-2,718
-16% -$23K
HL icon
762
Hecla Mining
HL
$11.1B
$111K ﹤0.01%
23,180
-3,380
-13% -$14.9K
BTG icon
763
B2Gold
BTG
$5.46B
$94.3K ﹤0.01%
29,926
+13,004
+77% +$41K
BLDP
764
Ballard Power Systems
BLDP
$796M
$90.1K ﹤0.01%
24,360
-1,161
-5% -$4.13K
CHPT icon
765
ChargePoint
CHPT
$150M
$89K ﹤0.01%
1,901
+54
+3% +$3.02K
LYG icon
766
Lloyds Banking Group
LYG
$90.7B
$82.3K ﹤0.01%
34,450
EFXT
767
Enerflex
EFXT
$2.68B
$81.2K ﹤0.01%
+17,647
New +$76.9K
QS icon
768
QuantumScape Corp
QS
$3.4B
$75.9K ﹤0.01%
10,925
-3,282
-23% -$20.7K
ABUS icon
769
Arbutus Biopharma
ABUS
$913M
$72.6K ﹤0.01%
29,040
SAN icon
770
Banco Santander
SAN
$209B
$65.7K ﹤0.01%
15,876
SNDL icon
771
Sundial Growers
SNDL
$315M
$65.7K ﹤0.01%
40,046
HIVE
772
HIVE Digital Technologies
HIVE
$777M
$63.6K ﹤0.01%
+14,132
New +$48.2K
AWP
773
abrdn Global Premier Properties Fund
AWP
$370M
$60.3K ﹤0.01%
5,182
QNTM
774
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.6M
$55.5K ﹤0.01%
+943
New +$66.4K
LOOP icon
775
Loop Industries
LOOP
$33.2M
$54.5K ﹤0.01%
14,425

Similar funds

Scotia Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Scotia Capital held 847 positions worth $15.5B, up 12% from $13.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Scotia Capital's Q4 2023 filing shows 72 new, 341 increased, 338 reduced and 54 closed positions. Its largest new stake was BioNTech: 50,001 shares worth $5.28M. The largest sale was Walt Disney, an estimated $12.8M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

  • Scotia Capital's largest Q4 2023 buy was BioNTech: 50,001 shares worth $5.28M.
  • Scotia Capital added most to NVIDIA in Q4 2023, an estimated $24.3M increase.
  • Scotia Capital's biggest Q4 2023 reduction was Walt Disney, cutting an estimated $12.8M.
  • Scotia Capital fully exited Lithium Americas Corp. Common Shares in Q4 2023, selling an estimated $6.4M.
  • Scotia Capital's ten largest holdings make up 35% of its $15.5B portfolio in Q4 2023.
  • Scotia Capital opened 72 new positions and closed 54 in Q4 2023.
  • Scotia Capital's portfolio value rose 12% quarter-over-quarter to $15.5B.

Based on Scotia Capital's 13F filing for Q4 2023, filed 12 Feb 2024.